Oct
2026
Fiera Milano, Italy
Visit us
stand 14A76, Finished Dosage & Formulation

LABORATORIOS RUBIO,S.A.

Exhibitor at CPHI Milan 2026
About Us

Laboratorios Rubió, a family-owned company with 55 years experience, has been recognized for the development, manufacture and marketing of medicines with high therapeutical value for specialists as well as of certain drugs for life-threatening diseases, with long expertise in niche markets. Laboratorios Rubió's determination to meet the health needs of every single patient has led the company to be distinguished as per being pioneer of products targeted to low incidence diseases which affect only to a small number of patients.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    4
  • Employees:
    250 - 499
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • +34 937 722 509
  • Website
  • Calle Industria 29 , Polígono Industria Comte de Sert , 08755 , Castellbisbal, Barcelona, Spain
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 14A76, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Liposcale(R) novel advanced test

    Product Liposcale(R) novel advanced test

    The Liposcale(R) test is an advanced lipoprotein test based on nuclear magnetic resonance(NMR). From the analysis of serum or plasma samples by NMR, the concentration of cholesteroland triglycerides of the lipoprotein classes VLDL, IDL, LDL and HDL, the concentration ofparticles of the VLDL, LDL and HDL cl...
  • Methylphenidate Hydrochloride MR

    Product Methylphenidate Hydrochloride MR

    MR -  Treatment for children (over 6 years old), adolescents and adults with Attention Deficit Hyperactivity Disorder (ADHD). Box containing 30 capsules of 10/20/30/40/60 mg. Other packs are also available.

    Rubifen LA® is a bioequivalent generic of Ritalin LA® in the treatment of AD...
  • Guanfacine Hydrochloride

    Product Guanfacine Hydrochloride

    Guanfacine is indicated for the treatment of Attention Deficit and Hyperactivity Disorder (ADHD) in children and adolescents (6-17 years old) for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.Guanfacine must be used as a part of a comprehensive ADHD treatment programm...
  • Lisdexamfetamine dimesylate

    Product Lisdexamfetamine dimesylate

    Treatment for Attention Deficit Hyperactivity Disorder (ADHD).

    It is used in children, young people, and adults who have previously taken a methylphenidate treatment that inadequately treated their ADHD.

    It is not used as a treatment for ADHD in children under 6 years of age b...
  • Melatonin 1mg/ml Oral Solution

    Product Melatonin 1mg/ml Oral Solution

    Sleep onset insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where other healthy sleeping routines have not worked well enough.

    Short-term treatment of jet lag in adults.

    Strawberry flavour and contains Sorbitol.


    Bibliogr...

LABORATORIOS RUBIO SA Resources (1)